CL2023002953A1 - Composiciones de ácidos grasos poliinsaturados enriquecidos - Google Patents
Composiciones de ácidos grasos poliinsaturados enriquecidosInfo
- Publication number
- CL2023002953A1 CL2023002953A1 CL2023002953A CL2023002953A CL2023002953A1 CL 2023002953 A1 CL2023002953 A1 CL 2023002953A1 CL 2023002953 A CL2023002953 A CL 2023002953A CL 2023002953 A CL2023002953 A CL 2023002953A CL 2023002953 A1 CL2023002953 A1 CL 2023002953A1
- Authority
- CL
- Chile
- Prior art keywords
- fatty acids
- compositions
- enriched
- polyunsaturated fatty
- offer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title 1
- 150000002632 lipids Chemical class 0.000 abstract 3
- 230000002757 inflammatory effect Effects 0.000 abstract 2
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- -1 fatty acid esters Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Las presentes modalidades proporcionan una composición lipídica de origen vegetal que comprende altas concentraciones de ácidos grasos omega-3 de cadena larga, típicamente como ésteres de ácidos grasos, que comprenden DPA, DTA, ETA o ETrA, opcionalmente con OA o ALA. Estas composiciones lipídicas enriquecidas tienen una estabilidad mejorada y ofrecen una fuente sostenible de estos ácidos grasos omega-3 de cadena larga. En algunas modalidades, estas composiciones lipídicas enriquecidas muestran una modulación mejorada de marcadores inflamatorios, tal como la inhibición de citocinas inflamatorias, y ofrecen valor nutricional o terapéutico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926239P | 2019-10-25 | 2019-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023002953A1 true CL2023002953A1 (es) | 2024-04-12 |
Family
ID=73038258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023002953A CL2023002953A1 (es) | 2019-10-25 | 2023-10-03 | Composiciones de ácidos grasos poliinsaturados enriquecidos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220362199A1 (es) |
| EP (1) | EP4048252A1 (es) |
| JP (1) | JP2022554152A (es) |
| KR (1) | KR20220088902A (es) |
| CN (1) | CN114867476A (es) |
| AR (1) | AR122331A1 (es) |
| AU (1) | AU2020370081A1 (es) |
| BR (1) | BR112022007695A2 (es) |
| CA (1) | CA3155544A1 (es) |
| CL (1) | CL2023002953A1 (es) |
| CO (1) | CO2022005055A2 (es) |
| MX (2) | MX2022004887A (es) |
| PE (1) | PE20230178A1 (es) |
| TW (1) | TW202128142A (es) |
| WO (1) | WO2021079142A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1756280T3 (en) | 2004-04-22 | 2015-02-02 | Commw Scient Ind Res Org | SYNTHESIS OF CHAIN, polyunsaturated fatty acids BY RECOMBINANT CELLS |
| CN101663031A (zh) * | 2007-02-20 | 2010-03-03 | 马泰克生物科学公司 | 来自长链多不饱和脂肪酸的氧脂素及其制备方法和使用方法 |
| BRPI0921467B1 (pt) * | 2008-11-18 | 2021-12-14 | Commonwealth Scientific And Industrial Research Organisation | Processo para a produção de óleo compreendendo ácido eicosapentaenóico (epa), ácido docosapentaenóico (dpa) e ácido docosahexaenóico (dha) |
| EA036786B1 (ru) | 2012-06-15 | 2020-12-21 | Коммонвелт Сайнтифик Энд Индастриэл Рисерч Организэйшн | Выработка длинноцепочечных полиненасыщенных жирных кислот в растительных клетках |
| UA122768C2 (uk) | 2013-12-18 | 2021-01-06 | Коммонвелз Сайнтіфік Енд Індастріал Рисерч Организейшн | Екстрагований рослинний ліпід, що містить довголанцюгові поліненасичені жирні кислоти |
| EP3160482A4 (en) * | 2014-06-27 | 2018-02-14 | Commonwealth Scientific and Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
| CN116287385A (zh) | 2016-06-16 | 2023-06-23 | 纽希得营养澳大利亚私人有限公司 | 近交转基因油菜品系ns-b50027-4及其种子 |
| CN117947200A (zh) | 2016-06-16 | 2024-04-30 | 纽希得营养澳大利亚私人有限公司 | 优良种事件油菜ns-b50027-4 |
-
2020
- 2020-10-23 AR ARP200102935A patent/AR122331A1/es unknown
- 2020-10-23 MX MX2022004887A patent/MX2022004887A/es unknown
- 2020-10-23 EP EP20799808.9A patent/EP4048252A1/en active Pending
- 2020-10-23 CA CA3155544A patent/CA3155544A1/en active Pending
- 2020-10-23 PE PE2022000667A patent/PE20230178A1/es unknown
- 2020-10-23 AU AU2020370081A patent/AU2020370081A1/en active Pending
- 2020-10-23 CN CN202080074278.7A patent/CN114867476A/zh active Pending
- 2020-10-23 BR BR112022007695A patent/BR112022007695A2/pt unknown
- 2020-10-23 US US17/771,173 patent/US20220362199A1/en active Pending
- 2020-10-23 WO PCT/GB2020/052687 patent/WO2021079142A1/en unknown
- 2020-10-23 TW TW109136894A patent/TW202128142A/zh unknown
- 2020-10-23 JP JP2022523882A patent/JP2022554152A/ja active Pending
- 2020-10-23 KR KR1020227017412A patent/KR20220088902A/ko unknown
-
2022
- 2022-04-22 CO CONC2022/0005055A patent/CO2022005055A2/es unknown
- 2022-04-22 MX MX2023011681A patent/MX2023011681A/es unknown
-
2023
- 2023-10-03 CL CL2023002953A patent/CL2023002953A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR122331A1 (es) | 2022-08-31 |
| EP4048252A1 (en) | 2022-08-31 |
| AU2020370081A1 (en) | 2022-06-02 |
| MX2022004887A (es) | 2022-08-04 |
| US20220362199A1 (en) | 2022-11-17 |
| BR112022007695A2 (pt) | 2022-07-12 |
| MX2023011681A (es) | 2023-10-18 |
| KR20220088902A (ko) | 2022-06-28 |
| CO2022005055A2 (es) | 2022-11-29 |
| WO2021079142A1 (en) | 2021-04-29 |
| CA3155544A1 (en) | 2021-04-29 |
| CN114867476A (zh) | 2022-08-05 |
| PE20230178A1 (es) | 2023-02-01 |
| JP2022554152A (ja) | 2022-12-28 |
| TW202128142A (zh) | 2021-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ721036A (en) | Lipid comprising long chain polyunsaturated fatty acids | |
| CO6341615A2 (es) | Salicilatos acetilados con acidos grasos y sus usos. | |
| PE20151864A1 (es) | Composiciones nutricionales que contienen una fraccion enriquecida de lipido y usos del mismo | |
| MX2015008199A (es) | Formulaciones de acido eicosapentaenoico (epa). | |
| CO7121328A2 (es) | Composiciones de ester de ácido graso omega -3 | |
| MX342216B (es) | Composiciones de acidos grasos. | |
| PE20141998A1 (es) | Composiciones topicas que comprenden fipronilo y permetrina y sus metodos de uso | |
| GEP201606568B (en) | Compositions for the treatment of neurologic disorders | |
| AR113127A1 (es) | Composición que comprende aceite vegetal y vinagre de sidra de manzana | |
| PE20050138A1 (es) | Aceites de pescado con un perfil alterado de acidos grasos, un metodo para producir esos aceites y uso de ellos | |
| BR112014010347A2 (pt) | óleo contendo ácido graxo poliinsaturado oxidativamente estável | |
| IN2014DN05640A (es) | ||
| AR106625A1 (es) | Composiciones nutricionales que contienen butirato y usos de las mismas | |
| AR072579A1 (es) | Aceites no- trans funcionales con relacion omega-6 a omega -3 modulada | |
| CL2021001407A1 (es) | Acidos grasos de cadena muy larga | |
| CL2019003072A1 (es) | Composiciones nutricionales y farmacéuticas encapsuladas. | |
| CO2021000418A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con ala | |
| CO2020013126A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| CL2023002953A1 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos | |
| DK3826630T3 (da) | Sammensætninger af cannabinoider med polyumættede fedtsyremonoglycerider og anvendelser heraf | |
| AR122837A1 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| CO2021000430A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| CO2021000426A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| CO2021000431A2 (es) | Composiciones de ácidos grasos poliinsaturados enriquecidos con dha | |
| EA202092556A1 (ru) | Композиции полиненасыщенных жирных кислот, обогащенные дгк |